Cesar R. S.
- Country
- Spain
- Department
- -
Research Overview
- Phase III Randomized, Double-Blind Trial of Atezolizumab with Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
- Phase II Randomized Study of Neoadjuvant Chemotherapy and Nivolumab Versus Chemotherapy Alone in Locally Advanced Resectable Non-Small Cell Lung Cancer
- Evaluation of Patient Preference for Home Administration of Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab in HER2-Positive Breast Cancer
Data & Insights
Has run more than one trial at 307 of 566 partner sites.
Specializations
Lung Cancer Expertise
Specializes in advanced treatment approaches for non-small cell lung cancer (NSCLC), with particular focus on ALK-positive variants. Investigates innovative combinations of chemotherapy and immunotherapy for thoracic-confined cases.
- Resectable lung cancer management
- ALK mutation targeted therapies
- Stage IIIa and IIIb treatment protocols
Explores therapeutic approaches for both operable and non-operable lung cancer cases, integrating maintenance treatment strategies.
Breast Cancer Treatment
Focuses on diverse breast cancer subtypes, including HER2-positive, hormone receptor-positive, and triple-negative breast cancer. Specializes in early-stage disease management and novel therapeutic combinations.
- Neoadjuvant therapy approaches
- HER2-targeted treatments
- Early-stage disease management
Investigates long-term outcomes in early-stage breast cancer and innovative treatment strategies for high-risk patients.
Precision Medicine Applications
Implements targeted therapeutic approaches for specific genetic profiles, including BRCA mutations and HER2 expression patterns. Explores personalized treatment strategies based on molecular characteristics.
- Mutation-specific therapies
- Biomarker-driven treatment selection
- Targeted therapeutic protocols
Develops treatment protocols tailored to specific genetic markers and molecular profiles of cancer types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.